AHN West Penn Leads the Way in Robotic-Assisted Hysterectomy Trials

Introduction

In a significant leap towards advancing women's healthcare, Allegheny Health Network (AHN) West Penn Hospital announced its participation as the first U.S. site in a clinical study evaluating the Medtronic Hugo™ robotic-assisted surgery (RAS) system for gynecological procedures. Known as the 'Embrace Gynecology' study, this investigational device exemption (IDE) clinical trial is set to explore the safety and effectiveness of this innovative surgical technology in performing hysterectomies.

Significance of the Study

The 'Embrace Gynecology' clinical trial marks a vital step in broadening minimally invasive surgical options for women diagnosed with gynecological conditions. Traditional surgical methods for performing hysterectomies often result in longer recovery times and more complications. By utilizing the robotic-assisted approach, surgeons aim to enhance patient outcomes significantly. The study will engage up to 70 participants across a maximum of five hospitals in the United States, with AHN West Penn being the first to conduct the groundbreaking procedure.

First Procedure

On November 7, 2025, AHN West Penn made history by successfully completing the very first total hysterectomy using the Hugo RAS system. This important milestone was accomplished by leading gynecological oncology surgeons, Dr. Sarah Crafton and Dr. Eirwen Miller. "For women facing a gynecologic diagnosis, our goal is always to provide the most effective treatment with the quickest possible recovery," Dr. Miller remarked, highlighting AHN's commitment to pioneering innovative solutions in women's health.

Trial Framework

The trial aims to assess the performance of the Hugo RAS system specifically in hysterectomies for both malignant and benign conditions, which includes a spectrum of gynecological cancers. Surgical procedures often represent a leading therapy for various conditions such as fibroids, abnormal bleeding, and cancers including endometrial cancer. As noted by Dr. Miller, with estimates from the National Cancer Institute suggesting nearly 111,000 new gynecological cancer cases in the U.S. within a year, advancing surgical methods is crucial for enhancing patient care.

Benefits of Robotic Surgery

Robotic-assisted surgeries have transformed the way gynecological procedures are undertaken. As noted by Dr. Thomas C. Krivak, Vice Chair of Research at AHN Women’s Institute, the introduction of minimally invasive surgery, particularly robotic techniques, provides multiple patient benefits. These include reduced complication rates, shorter hospitalization periods, smaller incisions, and quicker returns to everyday activities.

AHN’s Leadership Role

AHN West Penn's distinguished gynecologic oncology team is recognized for performing approximately 1,200 hysterectomies annually, many involving patients with various forms of gynecological cancer. With this study, AHN reinforces its position as a leader in gynecological care, dedicated to both innovation and optimal patient outcomes. By partaking in this significant clinical trial, the network aims to collect essential data that will help refine and expand surgical options available to women.

Holistic Gynecological Care

In addition to robotic-assisted interventions, AHN’s comprehensive gynecologic cancer team adopts a multidisciplinary approach in treating patients facing reproductive cancers, offering various therapies such as surgical implants for advanced radiation, immunotherapy, fertility-sparing options, and access to prominent clinical trials across the nation.

Recognition and Future Directions

For the fourth consecutive year, AHN West Penn has earned a spot in the top 50 hospitals for obstetrics and gynecology as per the U.S. News and World Report, underlining its excellence in delivering high-quality health services. The 'Embrace' clinical trial is the third IDE study conducted by Medtronic concerning this specific robotic technology, which has shown promising safety and effectiveness in previous trials.

AHN remains committed to enhancing gynecological care through groundbreaking studies and the integration of advanced technology, ensuring that women receive the best possible care throughout their healthcare journey.

Conclusion

For more information about the AHN Women's Institute or to schedule an appointment, visit ahn.org or call 412-DOCTORS. Through innovations like the Hugo RAS system and dedicated clinical investigations, AHN West Penn is leading the way in transforming women’s health.